Safer mass production of endocrine cells for stem cell-derived therapy for diabetes
Detailed analysis focusing on non-endocrine cells and validation of identified markers for detecting non-endocrine subpopulations. (a) Newly classified cell populations by reference component analysis
Updated on: November 02,2023
8

Safer mass production of endocrine cells for stem cell-derived therapy for diabetes
Detailed analysis focusing on non-endocrine cells and validation of identified markers for detecting non-endocrine subpopulations. (a) Newly classified cell populations by reference component analysis
Updated on:November 02,2023
8
